ILMN:NASDAQ
Illumina Inc
$278.19
arrow_upward
+1.89%(+5.15) 1D
Oct 5, 10:46:24 AM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ILMN...
Open
$273.00
High
$280.00
Low
$271.61
Mkt. cap
42.03B
Avg. vol.
3.40M
Volume
524.65K
P/E ratio
51.74
52-wk high
$280.16
52-wk low
$88.00
EPS
$5.38
Beta
1.41
Shares outstanding
151.00M
No. of employees
9K
Open
$273.00
High
$280.00
Low
$271.61
Mkt. cap
42.03B
Avg. vol.
3.40M
Volume
524.65K
P/E ratio
51.74
52-wk high
$280.16
52-wk low
$88.00
EPS
$5.38
Beta
1.41
Shares outstanding
151.00M
No. of employees
9K
News stories
From web sources and news partners
Investing.com
·
24 minutes ago
RBC Capital raises Illumina stock price target on clinical sales
AD HOC NEWS
·
1 hour ago
RBC raises target for Illumina stock to USD 310
AD HOC NEWS
·
1 day ago
Illumina stock gains 2.74 percent as Guggenheim lifts target
Profile
Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets, and serves more than 155 countries.
Illumina's customers include genomic research centers, pharmaceutical companies, academic institutions, clinical research organizations, and biotechnology companies. Wikipedia
About Illumina Inc
CEOJacob Thaysen
Employees8.62K
Founded1998
HeadquartersSan Diego, California, United States
SectorHealth care
Websiteillumina.com